Xolair (2019-09-06)

Starting date:
September 6, 2019
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-70947

Last updated:

Summary

  • Product: Xolair

Reason

Affected lot may contain the presence of silicone oil.

Depth of distribution

Retailers

Affected products

Xolair

DIN, NPN, DIN-HIM

DIN 02260565

Dosage form

Powder For Solution 

Strength

Omalizumab 150mg/Vial

Lot or serial number

SR532

Companies

Recalling Firm
Novartis Pharmaceuticals Canada Inc.
2476 Argentia Road, Unit 404
Mississauga
L5N 6M1
Ontario
CANADA
Marketing Authorization Holder
Novartis Pharmaceuticals Canada Inc.
385 Bouchard Boulevard
Dorval
H9S 1A9
Quebec
CANADA